Adocia SA/€ADOC
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Adocia SA
Adocia SA is a clinical-stage biotechnology company headquartered in Lyon, France, specializing in the development of innovative formulations of therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Founded in 2005 by Gérard Soula and his sons Olivier and Rémi, the company has developed a proprietary BioChaperone® technology platform designed to enhance the efficacy and safety of therapeutic proteins. Adocia's clinical pipeline includes products such as BioChaperone Lispro, an ultra-rapid insulin formulation, and BioChaperone Combo, a combination of basal and rapid-acting insulins. The company has established a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize its products in China and other Asian and Middle Eastern territories. (,)
Ticker
€ADOC
Sector
Primary listing
PAR
Employees
77
Headquarters
Website
Adocia SA Metrics
BasicAdvanced
€84m
-
-
0.28
-
Price and volume
Market cap
€84m
Beta
0.28
52-week high
€12.34
52-week low
€3.47
Average daily volume
43k
Financial strength
Interest coverage (TTM)
-18.79%
Profitability
EBITDA (TTM)
-15.268
Gross margin (TTM)
-267.83%
Net profit margin (TTM)
-431.16%
Operating margin (TTM)
-409.67%
Effective tax rate (TTM)
0.07%
Revenue per employee (TTM)
€50,000
Management effectiveness
Valuation
Growth
Revenue change (TTM)
-68.26%
3-year revenue growth (CAGR)
-39.48%
10-year revenue growth (CAGR)
-21.76%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
FAQs